{
    "nctId": "NCT03249311",
    "officialTitle": "Effectiveness of the Norepinephrine and Serotonin Reuptake Inhibitor Levomilnacipran in Healthy Males",
    "genderBased": true,
    "inclusionCriteria": "* Male participants between 18 and 40 years-old\n* Written informed consent signed by the participant\n* Must be MALE\n* Must have minimum age of 18 Years\n* Must have maximum age of 40 Years",
    "exclusionCriteria": "* Lifetime personal history of diagnosis of major depressive disorder according to the DSM-V (American Psychiatric Association, 2013) using the Structured Clinical Interview for DSM-V Axis I Disorders, Research Version, Non-patient Edition (SCID-5-RV for DSM-V; First et al., 2015)\n* A history of suicidal ideation and behaviour, including self-harm and/or harm to others.\n* A history of substance abuse and/or dependence.\n* A positive drug screen for illicit drugs\n* Substantial alcohol use\n* Current use of Monoamine Oxidase Inhibitors (MAOIs), including the antibiotic linezolid and the thiazine dye methylthioninium chloride (methylene blue)\n* Current use of serotonin-precursors (such as L-tryptophan, oxitriptan)\n* Current use of serotonergic drugs (triptans, certain tricyclic antidepressants, lithium, tramadol, St. John's Wort)\n* Concomitant use of NSAIDS, ASA, and other anticoagulants.\n* Current use of Thioridazine\n* Current use of CYP1A2 Inhibitors\n* Current use of Triptans (5HT1 Agonists)\n* Blood pressure greater than 140/90 and/or a pulse rate greater than 90 bpm\n* Recent history of myocardial infarction, cerebrovascular accident, cardiac arrhythmias, or unstable heart disease.\n* Evidence of significant physical illness contraindicating the use of levomilnacipran and duloxetine found on the physical exam or in the laboratory data obtained during the first week of the study\n* Current use of medication that may affect voiding (ie- anticholinergics)\n* History of obstructive urinary disorders and dysuria, prostatic hypertrophy, prostatitis, and other lower urinary tract obstructive disorders.\n* History of Stevens-Johnson Syndrome and Erythema multiforme.\n* Diabetes Type I and II\n* Fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase insufficiency.\n* Hepatic Impairment\n* Uncontrolled narrow-angle glaucoma\n* Severe renal impairment\n* History of seizure disorder\n* Anatomically narrow ocular angles.\n* Osteoporosis or major risk for bone fractures."
}